PRECISION BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.38 USD | -3.50% |
|
-3.70% | -14.34% |
| Apr. 16 | Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration | MT |
| Apr. 16 | Transcript : Precision BioSciences, Inc. - Special Call |
Chart calendar Precision BioSciences, Inc.
756c11072a23566422df4f5e29b.ulSTDjoUXXgwb2D_qnVLa0qPMrIawA_V-M8LzNOA6gg.-BX-IwxbPw5YXBig-Rt5ADvrUf1siz6ilqFApYzGsEfxDOt6CVUSDFkkBw~f7e56795ff095001f4b40761aca92490
Upcoming events on Precision BioSciences, Inc.
No events available
Past events on Precision BioSciences, Inc.
| 2023-12-05 04:30 pm | IHE Hep DART Conference - Poster No:42 |
| 2023-12-05 01:55 pm | IHE Hep DART Conference - Jeff Smith |
| 2023-11-15 10:45 am | Sidoti Microcap Virtual Conference |
| 2023-11-13 04:30 pm | American Association for the Study of Liver Diseases Conference |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster No 5040-C |
| 2023-11-09 | American Association for the Study of Liver Diseases Conference |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-10-25 11:00 am | European Society of Gene and Cell Therapy Conference - Poster Number: #P641 |
| 2023-10-25 11:00 am | European Society of Gene and Cell Therapy Conference - Poster Number: Poster #P653 |
| 2023-10-25 09:30 am | H.C. Wainwright NASH Investor Conference - Fireside Chat |
| 2023-10-09 | Cell & Gene Meeting on the Mesa Conference |
| 2023-09-27 08:30 am | Jefferies Cell & Genetic Medicine Summit |
| 2023-09-12 09:00 am | R&D Day |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-04 07:00 am | Q2 2023 Earnings Release |
| 2023-06-22 12:15 pm | EASL Congress - Abstract Number: OS-034 |
| 2023-06-15 11:40 am | Goldman Sachs Global Healthcare Conference |
| 2023-06-09 10:30 am | Jefferies Global Healthcare Conference |
| 2023-05-31 08:30 am | Allogeneic CAR T Programs Update Call |
| 2023-05-30 02:25 pm | Stifel Tailoring Genes Genetic Medicines Day |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,2 22,7 -2.08% | 24,3 21,1 15.17% | 116 114 1.01% | 25,1 21,5 16.51% | 48,7 54,6 -10.78% | 21,2 |
|
EBITDA Million USD | Released Forecast Spread | -81,9 -88,5 7.44% | -101 -104 3.14% | -30,4 -32,1 5.18% | -92,6 -96,4 3.94% | -36,9 -46,5 20.58% | -40,1 |
|
EBIT Million USD | Released Forecast Spread | -87,2 -91,0 4.14% | -110 -84,8 -29.54% | -39,4 -42,2 6.58% | -100 -102 1.54% | -43,7 -61,8 29.26% | -61,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -92,9 -97,7 4.93% | -109 -78,1 -39.51% | -30,6 -41,9 26.89% | -112 -108 -3.65% | -61,3 -55,9 -9.64% | -50,5 |
|
Net income Million USD | Released Forecast Spread | -92,9 -97,7 4.93% | -109 -78,1 -39.6% | -30,6 -41,7 26.66% | -112 -108 -3.65% | -61,3 -54,6 -12.34% | -50,5 |
|
EPS USD | Released Forecast Spread | -66,3 -69,9 5.15% | -62,7 -49,9 -25.56% | -15,6 -19,5 19.99% | -38,1 -36,6 -3.98% | -16,0 -14,2 -12.79% | -7,40 |
| Announcement Date | 10/03/20 | 18/03/21 | 15/03/22 | 09/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,34 5,04 25.81% | 3,32 7,23 -54.09% | 3,82 5,11 -25.2% | 7,36 5,97 23.35% | 10,6 6,71 58.03% | 8,78 6,47 35.73% | 19,8 7,34 169.47% | 13,1 10,2 29.16% | 7,04 14,5 -51.32% | 6,43 | 6,99 | 5,39 | 5,59 | 10,0 |
|
EBITDA Million USD | Released Forecast Spread | -28,6 -29,4 2.81% | -25,4 -30,6 17.07% | -27,7 -23,2 -19.28% | -21,0 -23,4 10.3% | -18,5 -22,1 16.16% | -22,5 -22,7 0.83% | -10,0 -23,1 56.61% | -10,7 -20,5 47.6% | -13,6 8,60 -258.27% | -6,30 | -12,1 | -12,7 | -12,3 | |
|
EBIT Million USD | Released Forecast Spread | -30,8 -33,5 8.14% | -27,3 -34,5 20.62% | -29,6 -27,7 -7.05% | -22,9 -28,3 18.95% | -20,5 -25,4 19.23% | -24,5 -25,5 4.15% | -12,0 -26,9 55.47% | -12,4 -19,6 36.88% | -14,9 -9,63 -54.7% | -13,5 | -13,2 | -15,1 | -15,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,3 -33,3 33.09% | -28,2 -34,4 18.12% | -31,0 -27,8 -11.74% | -23,9 -29,4 18.54% | -17,2 -26,1 33.93% | -25,1 -24,8 -0.98% | -11,9 -26,9 55.75% | -12,1 -20,7 41.47% | -16,3 -4,65 -250.68% | -12,7 | -12,3 | -14,7 | -14,8 | |
|
Net income Million USD | Released Forecast Spread | -22,3 -33,3 33.09% | -28,2 -34,4 18.12% | -31,0 -27,8 -11.74% | -23,9 -29,4 18.54% | -17,2 -26,1 33.93% | -25,1 -24,8 -0.98% | -11,9 -26,9 55.75% | -8,08 -20,7 60.95% | -16,3 -4,65 -250.68% | -12,7 | -12,3 | -14,7 | -14,8 | |
|
EPS USD | Released Forecast Spread | -11,4 -14,8 22.99% | -13,8 -17,0 18.73% | -13,8 -12,2 -12.88% | -6,60 -7,95 16.98% | -6,90 -6,26 -10.27% | -6,90 -6,75 -2.22% | -3,00 -7,08 57.63% | -2,10 -5,00 58% | -15,6 -2,03 -666.5% | -1,90 | -1,83 | -2,09 | -1,80 | -0,85 |
| Announcement Date | 15/03/22 | 09/05/22 | 08/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 04/08/23 | 07/11/23 | 27/03/24 | - | - | - | - | - |
Past sector events for Precision BioSciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DTIL Stock
- Calendar Precision BioSciences, Inc.
